Feedback plc (FDBK.L) Research

Feedback plc is a medical technology company, headquartered in London, UK, and established in 1958, that supplies specialized software and systems to individuals and organizations working within the medical imaging sector. Their product portfolio includes TexRAD, a patented software tool designed to extract and quantify textural features within radiological images. This assists research into all types of tumors and helps uncover biomarkers in medical imagery. They also offer TexRAD Lung, a specific software tool used for the clinical analysis of lung cancer within the European Union. Additionally, the company provides the Cadran image platform, a robust picture archiving and communication system (PACS) for hospitals and research institutes, capable of handling images from various imaging modalities like CT and PET scanners. Another key offering is Bleepa, a secure platform for clinical communications that facilitates the safe sharing of high-quality medical images.

Market snapshot

Symbol
FDBK.L
Price
$7.40
Day change
0.00%
Market cap
$3.2M
P/E ratio
-0.45x
52-week range
7.3-15
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 4 months

Peer companies

  • Chill Brands Group PLC (CHLL.L)
  • CRISM Therapeutics Corporation (CRTX.L)
  • Genedrive Plc (GDR.L)
  • MyHealthChecked PLC (MHC.L)
  • N4 Pharma Plc (N4P.L)
  • Polarean Imaging plc (POLX.L)
  • Proteome Sciences plc (PRM.L)
  • Theracryf Plc (TCF.L)

Open Feedback plc (FDBK.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.